A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer’s Disease by Peptidome Technology

BACKGROUND: Because dementia is an emerging problem in the world, biochemical markers of cerebrospinal fluid (CSF) and radio-isotopic analyses are helpful for diagnosing Alzheimer’s disease (AD). Although blood sample is more feasible and plausible than CSF or radiological biomarkers for screening p...

Descripción completa

Detalles Bibliográficos
Autores principales: Abe, Koji, Shang, Jingwei, Shi, Xiaowen, Yamashita, Toru, Hishikawa, Nozomi, Takemoto, Mami, Morihara, Ryuta, Nakano, Yumiko, Ohta, Yasuyuki, Deguchi, Kentaro, Ikeda, Masaki, Ikeda, Yoshio, Okamoto, Koichi, Shoji, Mikio, Takatama, Masamitsu, Kojo, Motohisa, Kuroda, Takeshi, Ono, Kenjiro, Kimura, Noriyuki, Matsubara, Etsuro, Osakada, Yosuke, Wakutani, Yosuke, Takao, Yoshiki, Higashi, Yasuto, Asada, Kyoichi, Senga, Takehito, Lee, Lyang-Ja, Tanaka, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029318/
https://www.ncbi.nlm.nih.gov/pubmed/31771070
http://dx.doi.org/10.3233/JAD-191016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029318/
https://www.ncbi.nlm.nih.gov/pubmed/31771070
http://dx.doi.org/10.3233/JAD-191016

Ejemplares similares